Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer [Phase 2]
Phase 2 trial updates reported results for bevacizumab with Abraxane in recurrent epithelial ovarian cancer and primary peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [Phase 1]
Phase 1 study evaluating a conditioning regimen of melphalan and thiotepa followed by peripheral stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED) [Phase 4]
Phase 4 study completed evaluating efficacy and tolerability of Caelyx in patients with epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel plus carboplatin followed by gemcitabine plus carboplatin for epithelial ovarian cancer has completed.